South Korea · Delayed Price · Currency is KRW Penetrium Bioscience Company Description
Penetrium Bioscience Inc., a contract research organization, provides clinical services in Asia.
It offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs.
The company also provides pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance; and quality assurance services.
In addition, it develops, manufactures, and sells medical microneedle patches. The company was formerly known as Hyundai ADM Bio Inc. and changed its name to Penetrium Bioscience Inc. in March 2026.
Penetrium Bioscience Inc. was founded in 2003 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 2003 |
| Industry | Commercial Physical and Biological Research |
| Employees | 160 |
| CEO | Hyun-woo Kim |
Contact Details
Address: #711, 19, Saemunanro5gil Seoul, 03173 South Korea | |
| Phone | 82 2 730 1457 |
| Website | penetriumbio.com |
Stock Details
| Ticker Symbol | 187660 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Hyun-woo Kim | Chief Executive Officer |
| Dohyeong Na | Chief Financial Officer |